课题基金 / 基金详情

COVID-19 Variant Supplement - Cellular Immuno-Therapy for COVID-19 Induced Acute Respiratory Distress Syndrome: the CIRCA-19 Trial

COVID-19 Variant Supplement - Cellular Immuno-Therapy for COVID-19 Induced Acute Respiratory Distress Syndrome: the CIRCA-19 Trial
COVID-19 变异补充剂 - 针对 COVID-19 诱发的急性呼吸窘迫综合征的细胞免疫疗法:CIRCA-19 试验
批准号:
443293
负责人:
Stewart Duncan J
金额:
$3.64万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-02-01 至 2022-02-01

项目摘要

项目成果

Stewart Duncan J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The number of patients with the novel COVID-19 disease continues to rise world-wide. Approximately 20% of patients require hospitalization, and up to a quarter of these need intensive medical care, mainly due to intense inflammation (swelling) of the lung
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imbalance Between Vascular Injury and Repair in PAH
  • 批准号:
    469687
  • 项目类别:
    Operating Grants
  • 资助金额:
    $63.25万
  • 财政年份:
    2022
  • 负责人:
    Stewart Duncan J
  • 依托单位:
Microvascular Endothelial Loss and Regeneration in Acute Lung Injury
  • 批准号:
    462755
  • 项目类别:
    Operating Grants
  • 资助金额:
    $85.82万
  • 财政年份:
    2022
  • 负责人:
    Stewart Duncan J
  • 依托单位:
Cellular Immuno-Therapy for COVID-19 Induced Acute Respiratory Distress Syndrome: the CIRCA-19 Trial
  • 批准号:
    429558
  • 项目类别:
    Operating Grants
  • 资助金额:
    $135.54万
  • 财政年份:
    2020
  • 负责人:
    Stewart Duncan J
  • 依托单位:
A national platform to study inflammatory acute lung injury
  • 批准号:
    412374
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.73万
  • 财政年份:
    2019
  • 负责人:
    Stewart Duncan J
  • 依托单位:
海外基金